Global Sialolithiasis Treatment Market - Industry Trends and Forecast to 2029

Market Analysis and Insights Global Sialolithiasis Treatment Market

Sialolithiasis treatment market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.70% in the above mentioned forecast period.

The medical word for salivary gland stones is sialolithiasis. Calcium is the main component of these stones, although they also contain potassium, magnesium and ammonium. Sialolithiasis affects just a small percentage of children. Men between the ages of 30 and 60 are the most typically affected. The most common symptom is cyclical gland swelling and pain that occurs after eating certain foods. The calcium and phosphate in saliva can form a stone under certain conditions, such as dehydration, which causes thickening, or a decrease in the water content of the saliva. Stones commonly occur in the salivary ducts and can completely clog or partially obstruct the duct.

The rise in the prevalence of sialolithiasis is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of sialolithiasis treatment market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, growing government funding and rising initiatives by public and private organisations to spread awareness are the factors that will expand the sialolithiasis treatment market. Other factors such as increasing population of elderly people and growing number of cases of gout and autoimmune diseases will positively impact the sialolithiasis treatment market’s growth rate. Additionally, high prevalence of smoking and increasing consumption of medicines such as diuretics and anticholinergics will increase the risk of sialolithiasis and further result in the expansion of sialolithiasis treatment market.

Moreover, the rise in the research and development activities and high unmet need of current treatment will provide beneficial opportunities for the sialolithiasis treatment market in the forecast period of 2022-2029. Also, developments in the healthcare technology will escalate the growth rate sialolithiasis treatment market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of sialolithiasis treatment market. Additionally, complications involved with sialolithiasis treatment will hinder the sialolithiasis treatment market growth. Less awareness about sialolithiasis treatment will further challenge the market in the forecast period mentioned above.

This sialolithiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sialolithiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sialolithiasis Treatment Market Scope and Market Size

The sialolithiasis treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the sialolithiasis treatment market is segmented into surgical excision, medication and others. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs (NSAID), sialagogues and antibiotics.
• On the basis of diagnosis, the sialolithiasis treatment market is segmented into x-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), ultrasound, sialography and others.
• On the basis of symptoms, the sialolithiasis treatment market is segmented into pain, difficulty opening the mouth, redness, difficulty swallowing, painful lump under the tongue, fever, gritty or strange tasting saliva, fatigue, dry mouth, swelling, and others.
• On the basis of dosage, the sialolithiasis treatment market is segmented into injection, tablets and others.
• On the basis of route of administration, the sialolithiasis treatment market is segmented into oral, parenteral and others.
• On the basis of end-users, the sialolithiasis treatment market is segmented into clinic, hospital and others.

The sialolithiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Sialolithiasis Treatment Market Country Level Analysis

Sialolithiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the sialolithiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the sialolithiasis treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sialolithiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sialolithiasis Treatment Market Share Analysis

Sialolithiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sialolithiasis treatment market research.

Some of the major players operating in the sialolithiasis treatment market are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi, Abbott, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Private Limited, Mylan N.V., Allergan, Merck & Co., Inc., Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, and Takeda Pharmaceutical Company Limited., among others.

SKU-67516